JGRW vs QLTY

JGRWCJensen Quality Growth ETF

QLTYAGMO US Quality ETF

In short

JGRW Jensen's in-house quality-and-growth screen, put in an ETF wrapper in 2024. No index license, no closet benchmark: one manager's definition of a durable US grower, priced right at the middle of its peer group.

QLTY Most quality ETFs run a rules screen. QLTY hands the job to GMO's stock pickers, who buy US companies they judge high quality and chase plain total return. Active conviction, priced like it: 0.50% a year.

Stated mandate

JGRW The Fund seeks long-term capital appreciation.

QLTY The Fund seeks total return. It is actively managed and invests primarily in equities of U.S. companies that GMO believes are high quality.

Why people hold it

• JGRW The screen is the product: a named, proprietary quality-and-growth test on US stocks, and the portfolio has stuck close to that stated brief.
• 0.57% a year is dead-center for its quality and free-cash-flow peer group. Human stock picking without an above-market toll.
• Plainly stated job: long-term capital appreciation from US equities, with cash paid out quarterly rather than dressed up as the main event.

• QLTY Actively managed, not index-tracking. GMO's team chooses the US companies it considers high quality, under a straightforward total-return mandate instead of a published factor formula.
• GMO's read on quality leans toward wide moats and free cash flow, so the lineup can look meaningfully different from the index-built quality funds it sits beside.
• Opened in 2023 and already a multi-billion-dollar fund with moderate daily trading and a quarterly distribution schedule.
• The filings match the label: a standard 1940-Act fund holding US equities, screened on quality, no derivative wrapper or offshore complexity.

Worth knowing

• JGRW Trading is light. Spreads can widen at the open and close, so how you place the order matters more here than in a mega-cap index fund.
• Launched in 2024, so there is only a short live record. Its risk profile is measured off limited history and sits in the lower half of its cohort.
• Cheaper quality exposure exists in the same cohort: PSET charges 0.15%. The extra cost here buys Jensen's selection, not quality as a factor.

• QLTY The 0.50% fee runs above the typical quality-cohort charge, and index-built rivals undercut it hard: QUAL at 0.15%, JQUA at 0.12%.
• No index to fall back on. Everything rides on GMO's stock selection, and the ETF's own record only starts in 2023.
• Mostly on that fee, it sits in the lower half of its US quality peer group even though it does the job its documents describe.

Full JGRW profile⁠

Full QLTY profile⁠